Related Experiment Video
Updated: Dec 1, 2025

09:06
Evaluation of the Curing of Adhesive Systems by Rheological and Thermal Testing
Published on: July 3, 2020
7.6K
A New Dual-cure Universal Simplified Adhesive: 18-month Randomized Multicenter Clinical Trial.
Operative Dentistry
|November 10, 2020
Summary
This study found that a dual-cure universal adhesive performed well in non-carious cervical lesion restorations over 18 months, regardless of the application method. The adhesive demonstrated reliable clinical outcomes, with high retention rates across all tested strategies.
Area of Science:
- Restorative Dentistry
- Dental Materials Science
- Clinical Trials
Background:
- Non-carious cervical lesions (NCCLs) are prevalent and require effective restorative solutions.
- Dual-cure universal adhesives offer versatility but require evaluation of different application strategies.
- Understanding long-term clinical performance is crucial for material selection in NCCL treatment.
Purpose of the Study:
- To evaluate the 18-month clinical performance of a new dual-cure universal adhesive (Futurabond U).
- To compare four different adhesive application strategies: self-etch only (SEE), selective enamel etching + self-etch (SET), etch-and-rinse with dry dentin (ERDry), and etch-and-rinse with wet dentin (ERWet).
- To assess restoration characteristics including retention, marginal adaptation, marginal staining, postoperative sensitivity, and caries recurrence.
Main Methods:
- A multicenter, double-blind, split-mouth randomized clinical trial involving 50 patients and 200 NCCLs.
- Restorations were placed using Futurabond U with four distinct adhesive strategies and Admira Fusion composite resin.
- Clinical evaluation followed FDI World Dental Federation criteria at baseline and follow-up points.
Main Results:
- High retention rates were observed across all groups after 18 months (92%-94%).
- Minor marginal discrepancies were noted in 19% of restorations, with slightly more in the SEE group.
- Clinically acceptable minor marginal discoloration was observed in 7% of restorations; no postoperative sensitivity or caries recurrence occurred.
Conclusions:
- Futurabond U demonstrated reliable clinical performance for NCCL restorations irrespective of the bonding strategy employed.
- The adhesive's performance was not significantly influenced by the self-etch or etch-and-rinse application modes.
- While generally successful, the self-etch group showed a trend towards more marginal discrepancies.
Related Concept Videos
Clinical Trials: Overview
4.3K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.3K
Clinical Trials
10.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.0K
Accelerated Curing of Concrete
337
Accelerating concrete curing is achieved by applying heat and additional moisture. This process accelerates the hydration of the cement, resulting in an earlier strength gain in the concrete. Steam curing is a method wherein the concrete products are either transported through a chamber on a conveyor belt or encased in plastic, allowing steam at atmospheric pressure to circulate freely around them. This process begins with a phase of moist curing that typically lasts between 3 to 5 hours, after...
337
Clinically Relevant Drug Product Specifications: Methods of Establishment
95
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
95
Bioequivalence studies: Biowaivers
96
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
96
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
1.0K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.0K

